1. Balkwill FR (1987) Antitumor effects of interferons in animals. In: Finter NB, Oldham RD (eds) Interferon, vol 4. Elsevier, Amsterdam, p 225
2. Bloom ET, Korn EL (1983) Quantification of natural cytotoxicity by human lymphocyte subpopulations isolated by density: heterogeneity of the effector cells. J Immunol Methods 58: 323–335
3. Boussiotis VA, Pangalis GA (1988) Randomized clinical trial with alpha-2b interferon in 26 stage-A untreated B-chronic lymphocytic leukemia patients. Nouv Rev Fr Hematol 30: 471–473
4. Bunn PA, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin SA, Oldham R (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101: 484–487
5. Cooper MR, Fefer A, Thompson J, Case DC jr, Kmepf R, Sacher R, Neefe J, Bickers J, Scarffe JH, Spiegel R, Bonnern E (1986) Alpha-2 interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. Cancer Treat Rep 70: 473–476